Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey
| dc.contributor.author | Elisaf, M. S. | en |
| dc.contributor.author | Nikas, N. | en |
| dc.date.accessioned | 2015-11-24T19:31:13Z | |
| dc.date.available | 2015-11-24T19:31:13Z | |
| dc.identifier.issn | 1940-1574 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23227 | |
| dc.rights | Default Licence | - |
| dc.subject | Aged | en |
| dc.subject | Cholesterol, LDL/blood | en |
| dc.subject | Coronary Disease/*blood/*drug therapy/epidemiology | en |
| dc.subject | Cross-Sectional Studies | en |
| dc.subject | Dose-Response Relationship, Drug | en |
| dc.subject | Drug Administration Schedule | en |
| dc.subject | Europe | en |
| dc.subject | Female | en |
| dc.subject | Greece | en |
| dc.subject | Guideline Adherence/*statistics & numerical data | en |
| dc.subject | Health Surveys | en |
| dc.subject | Humans | en |
| dc.subject | Hypercholesterolemia/*blood/*drug therapy/epidemiology | en |
| dc.subject | Hypolipidemic Agents/*administration & dosage | en |
| dc.subject | Lipids/*blood | en |
| dc.subject | Male | en |
| dc.subject | Medication Adherence/statistics & numerical data | en |
| dc.subject | Middle Aged | en |
| dc.subject | *Quality Assurance, Health Care | en |
| dc.title | Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey | en |
| heal.abstract | Surveys evaluating plasma lipid goal attainment in patients with coronary heart disease (CHD) show that hypercholesterolemia is inadequately treated. CEPHEUS (CEntralized Pan-European survey on tHE Undertreatment of hypercholeSterolemia)-Greece was part of a European multicenter, cross-sectional survey to evaluate the proportion of patients on lipid-lowering drugs (LLDs) for >or=3 months, without dose modifications for at least 6 weeks, who reach their low-density lipoprotein-cholesterol (LDL-C) target. A total of 1321 Greek patients comprised the full analysis set (FAS); 28% were smokers, while 60.7%, 35.4%, 32.1%, and 25.1% had a history of hypertension, CHD, metabolic syndrome, and diabetes mellitus, respectively; 49.7% of the study population reached the Third Joint European Task Force (TJETF) LDL-C goals and 49.3% achieved the 2004-updated National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII) targets. Hypercholesterolemia is suboptimally managed in Greece, with almost 50% of patients on LLDs not reaching the LDL-C target. | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1177/0003319710366432 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/20462896 | - |
| heal.identifier.secondary | http://ang.sagepub.com/content/61/5/465.full.pdf | - |
| heal.journalName | Angiology | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2010 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: